Xvivo Perfusion AB Performance
| XVIPYDelisted Stock | USD 5.70 0.53 8.51% |
The firm maintains a market beta of 0.86, which attests to possible diversification benefits within a given portfolio. Xvivo Perfusion returns are very sensitive to returns on the market. As the market goes up or down, Xvivo Perfusion is expected to follow. Xvivo Perfusion AB right now maintains a risk of 0.0%. Please check out Xvivo Perfusion AB jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Xvivo Perfusion AB will be following its historical returns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Xvivo Perfusion AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Xvivo Perfusion is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Xvivo |
Xvivo Perfusion Relative Risk vs. Return Landscape
If you would invest 570.00 in Xvivo Perfusion AB on October 1, 2025 and sell it today you would earn a total of 0.00 from holding Xvivo Perfusion AB or generate 0.0% return on investment over 90 days. Xvivo Perfusion AB is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Xvivo, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Xvivo Perfusion Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Xvivo Perfusion's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Xvivo Perfusion AB, and traders can use it to determine the average amount a Xvivo Perfusion's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| XVIPY |
Based on monthly moving average Xvivo Perfusion is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Xvivo Perfusion by adding Xvivo Perfusion to a well-diversified portfolio.
Xvivo Perfusion Fundamentals Growth
Xvivo Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Xvivo Perfusion, and Xvivo Perfusion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Xvivo Pink Sheet performance.
| Return On Equity | 0.025 | |||
| Return On Asset | 0.0061 | |||
| Profit Margin | 0.08 % | |||
| Debt To Equity | 0 % | |||
| Cash Flow From Operations | (12.06 M) | |||
About Xvivo Perfusion Performance
Evaluating Xvivo Perfusion's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Xvivo Perfusion has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Xvivo Perfusion has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Xvivo Perfusion AB , a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden. Xvivo Perfusion is traded on OTC Exchange in the United States.Things to note about Xvivo Perfusion AB performance evaluation
Checking the ongoing alerts about Xvivo Perfusion for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Xvivo Perfusion AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Xvivo Perfusion AB is not yet fully synchronised with the market data | |
| Xvivo Perfusion AB has a very high chance of going through financial distress in the upcoming years | |
| Xvivo Perfusion generates negative cash flow from operations | |
| Latest headline from news.google.com: How higher bond yields impact Kali Metals Limited stock - Profit Target Free Daily Entry Point Trade Alerts - |
- Analyzing Xvivo Perfusion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Xvivo Perfusion's stock is overvalued or undervalued compared to its peers.
- Examining Xvivo Perfusion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Xvivo Perfusion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Xvivo Perfusion's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Xvivo Perfusion's pink sheet. These opinions can provide insight into Xvivo Perfusion's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Xvivo Pink Sheet
If you are still planning to invest in Xvivo Perfusion AB check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Xvivo Perfusion's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |